Cargando…
Drug Targets for Cell Cycle Dysregulators in Leukemogenesis: In Silico Docking Studies
Alterations in cell cycle regulating proteins are a key characteristic in neoplastic proliferation of lymphoblast cells in patients with Acute Lymphoblastic Leukemia (ALL). The aim of our study was to investigate whether the routinely administered ALL chemotherapeutic agents would be able to bind an...
Autores principales: | Jayaraman, Archana, Jamil, Kaiser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893288/ https://www.ncbi.nlm.nih.gov/pubmed/24454966 http://dx.doi.org/10.1371/journal.pone.0086310 |
Ejemplares similares
-
Identifying new targets in leukemogenesis using computational approaches
por: Jayaraman, Archana, et al.
Publicado: (2015) -
In silico evidence of signaling pathways of notch mediated networks in leukemia
por: Jamil, Kaiser, et al.
Publicado: (2012) -
The process of leukemogenesis.
por: Irons, R D, et al.
Publicado: (1996) -
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
por: Bäumer, Nicole, et al.
Publicado: (2015) -
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation
por: Cusan, Martina, et al.
Publicado: (2023)